<SEC-DOCUMENT>0001193125-23-050797.txt : 20230227
<SEC-HEADER>0001193125-23-050797.hdr.sgml : 20230227
<ACCEPTANCE-DATETIME>20230227162211
ACCESSION NUMBER:		0001193125-23-050797
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20230224
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230227
DATE AS OF CHANGE:		20230227

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Viatris Inc
		CENTRAL INDEX KEY:			0001792044
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				834364296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39695
		FILM NUMBER:		23675244

	BUSINESS ADDRESS:	
		STREET 1:		1000 MYLAN BOULEVARD
		CITY:			CANONSBURG
		STATE:			PA
		ZIP:			15317
		BUSINESS PHONE:		(724) 514-1465

	MAIL ADDRESS:	
		STREET 1:		1000 MYLAN BOULEVARD
		CITY:			CANONSBURG
		STATE:			PA
		ZIP:			15317

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Upjohn Inc
		DATE OF NAME CHANGE:	20191023
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d452663d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:vtrs="http://www.viatris.com/20230224" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2023-02-24_to_2023-02-24">Viatris Inc</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-02-24_to_2023-02-24">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-02-24_to_2023-02-24">0001792044</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="vtrs-20230224.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-02-24_to_2023-02-24"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-02-24</xbrli:startDate> <xbrli:endDate>2023-02-24</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-02-24_to_2023-02-24">8-K</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-02-24_to_2023-02-24" format="ixt:datemonthdayyearen">February&#160;24, 2023</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">VIATRIS INC.</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-02-24_to_2023-02-24" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-02-24_to_2023-02-24">001-39695</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-02-24_to_2023-02-24">83-4364296</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or Other Jurisdiction</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(I.R.S. Employer</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">of Incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">Identification No.)</span></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:99%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-02-24_to_2023-02-24">1000 Mylan Boulevard</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-02-24_to_2023-02-24">Canonsburg</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-02-24_to_2023-02-24" format="ixt-sec:stateprovnameen">Pennsylvania</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-02-24_to_2023-02-24">15317</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-02-24_to_2023-02-24">(724)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-02-24_to_2023-02-24">514-1800</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-02-24_to_2023-02-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-02-24_to_2023-02-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-02-24_to_2023-02-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2</span> (b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-02-24_to_2023-02-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4</span> (c))</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-02-24_to_2023-02-24">Common Stock, par value $0.01 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-02-24_to_2023-02-24">VTRS</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-02-24_to_2023-02-24" format="ixt-sec:exchnameen">The NASDAQ Stock Market</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-02-24_to_2023-02-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On February&#160;24, 2023, Viatris Inc. (the &#8220;Company&#8221;) appointed Scott A. Smith to serve as the Chief Executive Officer of the Company, effective as of April&#160;1, 2023, and to hold such office until his successor is chosen and qualified in his stead or until his earlier death, resignation or removal. Mr.&#160;Smith, age 60, is currently on the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) and most recently served as President of BioAtla, Inc. (&#8220;BioAtla&#8221;), a global biotechnology company focused on the development of Conditionally Active Biologics<sup style="font-size:75%; vertical-align:top">&#8482;</sup> antibody therapeutics, since 2018 and as a director of BioAtla since 2020. At BioAtla, Mr.&#160;Smith built a clinical development structure that moved multiple assets from investigational new drug applications into late stage clinical development, drove the company&#8217;s long-term strategic operational plan and led all business development activities, among other responsibilities. Prior to joining BioAtla, Mr.&#160;Smith was an executive at Celgene Corporation (&#8220;Celgene&#8221;), a global biopharmaceutical company, from 2008 to 2018, rising up the ranks from SVP and Global Head of Immunology to President of Inflammation and Immunology and then, beginning in 2017, President and Chief Operating Officer where he led the company&#8217;s oncology, inflammation and immunology franchise commercial operations and clinical development, among other responsibilities. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Smith also serves as chairman of the board of directors of Triumvira Immunologics. Mr.&#160;Smith previously served on the boards of directors of Refuge Biotechnologies, Inc. and Titan Pharmaceuticals, Inc., chairing that company&#8217;s Compensation and Nominating and Governance Committees, and as Chairman of <span style="white-space:nowrap">F-star</span> Therapeutics, Inc., serving on that company&#8217;s Audit and Nominating and Corporate Governance Committees. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In connection with his appointment, Mr.&#160;Smith entered into an offer letter with the Company providing for an annual base salary of $1.4&#160;million, an annual target bonus opportunity equal to 150% of base salary <span style="white-space:nowrap">(pro-rated</span> for 2023) and eligibility for an annual long-term incentive award with an intended value of 700% of base salary (800% for 2023). In the event of a termination without cause, Mr.&#160;Smith will be eligible for severance equal to the sum of his base salary and annual target bonus if such termination occurs on or prior to June&#160;30, 2024, two times the sum of base salary and annual target bonus if such termination occurs after June&#160;30, 2024 and two and a half times the sum of base salary and annual target bonus if such termination occurs within 24 month months following a change in control of the Company. Mr.&#160;Smith is eligible to participate in employee benefits and perquisites generally made available to executive officers of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">There are no arrangements or understandings between Mr.&#160;Smith and any other persons pursuant to which he was selected as Chief Executive Officer, he has no family relationships with any of the Company&#8217;s directors or executive officers and he has no direct or indirect material interest in any transaction requiring disclosure under Item 404(a) of Regulation <span style="white-space:nowrap">S-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Effective as of April&#160;1, 2023, Michael Goettler, the Company&#8217;s current Chief Executive Officer, will cease to serve in that role and will cease to serve on the Board. These actions were not related to any disagreement between Mr.&#160;Goettler and the Company on any matter relating to the Company&#8217;s operations, policies or practices. Mr.&#160;Goettler will be entitled to the separation benefits payable in accordance with the terms of his previously disclosed letter agreement with the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The offer letter with Mr.&#160;Smith and the separation agreement with Mr.&#160;Goettler are each filed as exhibits to this Form <span style="white-space:nowrap">8-K</span> and the foregoing summaries are qualified in their entirety by the terms of such agreements. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;7.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On February&#160;27, 2023, the Company issued a press release announcing the appointment of Mr.&#160;Smith and separation of Mr.&#160;Goettler.&#160;A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The information in this Item 7.01 (including Exhibit 99.1) shall not be deemed to be &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(d)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Exhibits. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Description</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d452663dex101.htm">Offer Letter with Scott A. Smith, dated February&#160;24, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d452663dex102.htm">Separation Agreement with Michael Goettler, dated February&#160;24, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d452663dex991.htm">Press Release, dated February&#160;27, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">VIATRIS INC.</td></tr>


<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: February&#160;27, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sanjeev Narula</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Sanjeev Narula</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d452663dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g452663g0227185324928.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1</B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXECUTION VERSION</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February&nbsp;24, 2023 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Scott
A. Smith </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o last address on file with the Company </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear
Scott: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On behalf of Viatris Inc. (the &#147;<U>Company</U>&#148;), I am pleased to confirm the terms of employment offered by the Company
in connection with your role as Chief Executive Officer of the Company effective as of April&nbsp;1, 2023 (the &#147;<U>Effective Date</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Position.</U> Your position shall be Chief Executive Officer, and you shall devote your full business time and attention to such
position. You shall report to the Board of Directors (the &#147;<U>Board</U>&#148;) and you shall perform such duties as requested by the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Work Location.</U> In the first twelve (12)&nbsp;months, it is anticipated that a significant portion of your working time will be spent
at Company offices in New York and/or Pittsburgh. You will also be required to travel as dictated by business needs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Base
Salary.</U> Your annual base salary shall be $1,400,000 (&#147;<U>Base Salary</U>&#148;), payable on the Company&#146;s standard payroll dates and subject to deductions and withholdings as required by applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Annual Incentive Bonus.</U> Your target bonus opportunity shall be 150% of Base Salary, and shall be prorated for 2023 to reflect a
partial year of service. The terms and conditions of the annual incentive plan applicable to the Company&#146;s officers, including the applicable performance goals, will be subject to the determination of the Board (or its applicable designee) each
year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Long-Term Incentive Awards.</U> During your employment with the Company, you shall be eligible to receive annual grants of
long-term incentive awards as determined by the Board (or its applicable designee). It is intended that the grant date value of such awards shall equal (i)&nbsp;for 2023, 800% of Base Salary and (ii)&nbsp;for all subsequent years of your employment
with the Company, 700% of Base Salary. The terms and conditions of the long-term incentive plan applicable to the Company&#146;s officers, including the applicable performance goals, the mix of long-term incentive vehicles and the timing of
applicable grants, will be subject to the determination of the Board (or its applicable designee) each year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Severance.</U> In the
event you are terminated by the Company without Cause (as such term is defined in the applicable Viatris severance plan) following the commencement of your employment, you will be entitled to receive a severance payment equal to (i)&nbsp;the
Severance Multiple multiplied by (ii)&nbsp;the sum of your Base Salary and target annual bonus in effect at the time of such termination. For purposes of this offer letter, the Severance Multiple means (x)&nbsp;one (1) in the event of a termination
on or prior to June&nbsp;30, 2024 and two (2)&nbsp;thereafter or (y)&nbsp;two and <FONT STYLE="white-space:nowrap">one-half</FONT> (2.5) in the event of a termination at any point within twenty-four (24)&nbsp;months following a Change in Control of
the Company (as defined in the Viatris 2020 Stock Incentive Plan). For the avoidance of doubt, you acknowledge and agree that upon any termination of your employment with the Company, you will be deemed to have immediately resigned from the Board
and the board of directors (or equivalent) of any of the Company&#146;s affiliates or subsidiaries and from any officer positions with the Company and its affiliates or subsidiaries. The severance hereunder, if applicable, will be paid to you in the
form of installments over a period of months corresponding to the severance period, on the Company&#146;s normal payroll dates, beginning no later than 60 days after your termination date, subject to your execution and non-revocation of the
customary Company release of claims agreement signed by similarly situated senior executive officers. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Benefits.</U> During your employment with the Company, you shall be eligible to
participate in all of the various employee benefit plans and programs which are made available to similarly situated officers of the Company, in accordance with the eligibility provisions and other terms and conditions of such plans and programs.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Miscellaneous.</U> The Company may deduct and withhold from any amount payable under this offer letter such Federal, state, local,
foreign or other taxes as are required to be withheld. The validity, interpretation, construction and performance of this offer letter will be governed by the laws of the Commonwealth of Pennsylvania (without giving effect to its conflicts of law).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This offer is also contingent upon execution by you of any applicable agreements relating to your employment with the Company (or an
affiliate of the Company) (including any applicable confidentiality and/or restrictive covenant agreement), in each case, in a form consistent with such agreement to be entered into with similarly situated Company officers, which may be provided to
you at a later date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To confirm your acceptance of this offer, please sign and return the original to me. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Your passion and commitment give us every reason to believe that together we will set new standards in healthcare and provide access to high
quality medicine for the world&#146;s 7&nbsp;billion people. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Andrew Enrietti</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Andrew Enrietti</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chief Human Relations Officer</TD></TR></TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Accepted:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Signature</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Scott A. Smith</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">February 24, 2023</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>d452663dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXECUTION VERSION </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SEPARATION
AGREEMENT AND RELEASE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Separation Agreement and Release (&#147;Agreement&#148;) is made by and between Michael Goettler
(&#147;Executive&#148;) and Viatris Inc. (together with its affiliates, the &#147;Company&#148;) (collectively referred to as the &#147;Parties&#148; or individually referred to as a &#147;Party&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS,
Executive shall separate from employment with the Company effective as of April&nbsp;1, 2023 (the &#147;Separation Date&#148;); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company and Executive wish to set forth the terms of such separation from employment with the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the mutual promises made herein and intending to be legally bound hereby, the Company and Executive hereby
agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COVENANTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Consideration and Other Terms of Separation.</U> Effective as of the Separation Date, Executive resigns from all positions as an
executive, officer, employee or director of the Company and all of its parents, subsidiaries and affiliates, and Executive shall cease to be the Chief Executive Officer of the Company or any of its parents, subsidiaries and affiliates.
Notwithstanding the foregoing, Executive hereby resigns from the Board of Directors of the Company (the &#147;Board&#148;) as of the date hereof, regardless of the Effective Date of this Agreement for all other purposes. Executive acknowledges and
agrees that his separation from the Company, including his resignation from the Board, is not because of a disagreement with the Company, including in his capacity as a member of the Board, on any matter relating to the operations, policies or
practices of the Company. Provided that Executive executes this Agreement and complies with its terms, and does not commit a material breach of this Agreement, as described in Section&nbsp;12 (<I>e.g., </I>Confidentiality, <FONT
STYLE="white-space:nowrap">Non-Competition,</FONT> <FONT STYLE="white-space:nowrap">Non-Solicitation)</FONT> below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. <U>Separation
Payment.</U> Executive shall be paid an amount equal to $8,125,000, subject to applicable deductions and withholdings required by applicable law (the &#147;Total Cash Separation Payment&#148;). The Total Cash Separation Payment and other payments
pursuant to this Agreement are expressly conditioned on Executive&#146;s compliance with the terms and conditions of this Agreement. The Total Cash Separation Payment shall be payable in the form of installments over a period of two and a half (2.5)
years on Viatris&#146; normal payroll dates; <I>provided</I>, <I>however</I>, that installments payable for the first six (6)&nbsp;months following the Separation Date shall be withheld and paid in a lump sum on the first regularly scheduled Company
payroll date occurring after the <FONT STYLE="white-space:nowrap">six-month</FONT> anniversary of the Separation Date. For the avoidance of doubt, the Total Cash Separation Payment represents payment in respect of your separation from employment and
your obligations hereunder and does not represent wages for prior service. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <U>Treatment of Equity-Based Awards.</U> All time-based restricted stock units
(&#147;RSUs&#148;) and performance-based RSUs (&#147;PRSUs&#148;), in each case, remain subject to the terms of the applicable long-term incentive plan or plans, as amended, and all applicable award agreements and amendments thereto. For the
avoidance of doubt, all unvested RSUs and PRSUs, in each case, granted in calendar years 2021 and 2022 held by the Executive as of the Separation Date shall be forfeited immediately upon the Separation Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. <U>Pro Rata Annual Incentive Payment for 2023.</U> Executive shall be paid a pro rata annual bonus for 2023, which shall be determined by
reference to the bonus Executive would have earned based on actual performance for 2023 and pro rated to reflect the number of days elapsed in the 2023 fiscal year through the Separation Date. The pro rata bonus shall be paid as soon as practicable
following the certification of applicable performance metrics for 2023, but in no event later than March&nbsp;15, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d.
<U>Benefits.</U> For a period of three years from the Separation Date, the Company shall continue to provide health and welfare benefits to Executive and/or Executive&#146;s eligible dependents at least equal to those that were provided to them
(taking into account any required employee contributions, <FONT STYLE="white-space:nowrap">co-payments</FONT> and similar costs imposed on the Executive and the Executive&#146;s dependents) by or on behalf of the Company in accordance with the
benefit plans, programs, practices and policies in effect immediately prior to the Separation Date; <I>provided</I> that to the extent the Executive and/or Executive&#146;s eligible dependents cannot be maintained on the Company&#146;s health and
welfare plans during such period the Company shall obtain comparable policies for the Executive and shall continue to pay that portion of the applicable costs that it pays on behalf of its actively employed executives who receive the same type of
coverage; <I>provided</I>, <I>further</I>, that, if the Executive becomes reemployed with another employer and is eligible for health benefits, the continued benefits provided herein shall immediately cease. For the avoidance of doubt, Executive
acknowledges and agrees that the period of continued benefits provided in this Section&nbsp;1(d) shall be concurrent with Executive&#146;s eligible benefit continuation period pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985,
as amended, which shall commence as of the first day of the month following the Separation Date. The Company will also (i)&nbsp;continue to provide Executive with tax preparation services consistent with past practice with respect to the 2023, 2024
and 2025 calendar years and (ii)&nbsp;reimburse Executive for reasonable expenses incurred in shipping or relocating household items from Pittsburgh, Pennsylvania. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. <U>401(k) Restoration Plan.</U> Executive shall be paid the accrued and vested benefit under the Company&#146;s 401(k) Restoration Plan (in
an amount currently equal to $646,747 and subject to increase based on the anticipated March deposit credit) in a lump sum on the first regularly scheduled Company payroll date occurring after the <FONT STYLE="white-space:nowrap">six-month</FONT>
anniversary of the Separation Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">f. <U>Vacation Pay</U>. The Company shall pay Executive for all unused and accrued vacation time as
of the Separation Date (in an amount equal to $125,000), less applicable deductions and withholdings required by applicable law. This payment shall be made in a lump sum and shall be paid on the Company&#146;s next regularly scheduled payroll date
after the Separation Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">g. <U>Other Benefits.</U> Executive&#146;s participation in all other benefits and incidents
of employment, including, but not limited to, the accrual of bonuses, vacation and paid time off, and any additional 401(k) plan contributions, shall cease as of the Separation Date. Vested amounts payable to Executive under the Company&#146;s
401(k) and other retirement plans or agreements shall be paid in accordance with the terms of such plans and agreements and applicable law. All payments hereunder shall be subject to applicable deductions and withholdings as required by applicable
law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Payment of Salary and Receipt of All Benefits.</U> Executive acknowledges and represents that, other than the consideration to
be paid pursuant to this Agreement, Executive&#146;s final regular pay on the Company&#146;s next regularly scheduled payroll date after the Separation Date and payment for all unused and accrued vacation time as of the Separation Date (which shall
be included in Executive&#146;s final regular pay on the Company&#146;s next regularly scheduled payroll date after the Separation Date, subject to applicable deductions and withholding), the Company has paid or provided all salary, wages, bonuses,
accrued vacation/paid time off, premiums, leaves, reimbursable expenses, stock, vesting, shares pursuant to vested restricted stock units, and any and all other benefits and compensation due to Executive by the Company and its affiliates. To receive
reimbursement for any final Company-related travel expenses, Executive must submit a final report of all such outstanding expenses within thirty (30)&nbsp;calendar days after the Separation Date, accompanied by receipts and otherwise subject to the
Company&#146;s expense reimbursement policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>General Release of Claims</U>. In consideration of the payments to be made under this
Agreement, which Executive acknowledges Executive would not otherwise be entitled to receive, Executive agrees that the foregoing consideration represents settlement in full of all outstanding obligations owed to Executive by the Company and its
current and former officers, directors, employees, agents, investors, attorneys, shareholders, administrators, affiliates, direct and indirect parents and subsidiaries, benefit plans, plan administrators, insurers, trustees, divisions and
subsidiaries, predecessor and successor corporations and assigns, and all persons acting with or on behalf of them (collectively, the &#147;Releasees&#148;). Executive, on Executive&#146;s own behalf and on behalf of Executive&#146;s heirs, family
members, executors, agents and assigns, hereby and forever releases and discharges the Releasees from any and all claims, complaints, charges, duties, obligations, demands or causes of action relating to any matters of any kind, whether presently
known or unknown, suspected or unsuspected, that Executive may possess against any of the Releasees arising from any omissions, acts, failures to act, facts or damages that have occurred up until and including the date Executive executes this
Agreement, including, without limitation: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. any and all claims relating to or arising from Executive&#146;s employment relationship with
the Company and/or any of the Releasees and the termination of that relationship; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. any and all claims relating to, or arising from,
Executive&#146;s right to purchase, or actual purchase of shares of stock of the Company and/or any of the Releasees, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable
state corporate law, and securities fraud under any state or federal law; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. any and all claims for wrongful discharge of employment; termination in violation of
public policy; discrimination; harassment; retaliation; breach of contract, both express and implied; breach of covenant of good faith and fair dealing, both express and implied; promissory estoppel; negligent or intentional infliction of emotional
distress; fraud; negligent or intentional misrepresentation; negligent or intentional interference with contract or prospective economic advantage; unfair business practices; defamation; libel; slander; negligence; personal injury; assault; battery;
invasion of privacy; false imprisonment; conversion; and disability benefits; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. any and all claims under any policy, agreement,
understanding or promise, written or oral, formal or informal, between any Releasee and Executive existing as of the date hereof (whether or not known or arising before, on or after the date Executive executes this Agreement); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. any and all claims for violation of any federal, state or municipal statute, including, but not limited to, Title VII of the Civil Rights
Act of 1964; the Civil Rights Act of 1991; the Rehabilitation Act of 1973; the Americans with Disabilities Act of 1990; the Equal Pay Act; the Fair Labor Standards Act; the Fair Credit Reporting Act; the Age Discrimination in Employment Act of 1967
(&#147;ADEA&#148;); the Older Workers Benefit Protection Act; the Employee Retirement Income Security Act of 1974; the Worker Adjustment and Retraining Notification Act; the Family and Medical Leave Act; the Sarbanes-Oxley Act of 2002; the laws and
Constitution of the Commonwealth of Pennsylvania, each as amended, or any other federal, state or local law, regulation ordinance or common law; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">f. any and all claims for violation of the federal or any state constitution; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">g. any and all claims arising out of any other laws and regulations relating to employment or employment discrimination; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">h. any claim for any loss, cost, damage, or expense arising out of any dispute over the
<FONT STYLE="white-space:nowrap">non-withholding</FONT> or other tax treatment of any of the proceeds received by Executive as a result of this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">i. any and all claims for attorneys&#146; fees and costs; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">j. any other claims whatsoever. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive
agrees that the Release set forth in this section shall be and remain in effect in all respects as a complete general release as to the matters released. This Release does not extend to any obligations incurred under this Agreement or any
indemnification agreement between Executive and the Company, any claims accruing after the execution of this Agreement, or any rights Executive may have under any D&amp;O insurance policy maintained by the Company and/or any of the Releasees. This
Release does not release claims that cannot be released as a matter of law, including, but not limited to, Executive&#146;s right to file a charge with or participate in a charge by, the Equal Employment Opportunity Commission, or any other local,
state or federal administrative body or government agency that is authorized to enforce or administer laws related to employment, against the Company (with the understanding that any such filing or participation does not give Executive the right to
recover any monetary damages against the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company and/or any of the Releasees; and Executive&#146;s release of claims herein bars Executive from recovering such monetary relief from the Company and/or any of the Releasees. Executive
represents that Executive has made no assignment or transfer of any right, claim, complaint, charge, duty, obligation, demand, cause of action or other matter waived or released by this Section&nbsp;3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Executive agrees that the consideration set forth in this Agreement is subject to Executive&#146;s execution, not later than 21 days following
the Separation Date, of this Release, and the <FONT STYLE="white-space:nowrap">non-revocation</FONT> of the Release during the period specified therein. If Executive fails to execute and deliver the Release within 21 days following the Separation
Date, or if Executive revokes the Release as provided therein, Executive shall forfeit his right to receive the compensation and benefits provided under this Agreement. In the event Executive signs this Agreement prior to the Separation Date, he
will be required to execute an affirmation of the Release upon his Separation Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Acknowledgment that Waiver of Claims is Knowing
and Voluntary</U>. Executive acknowledges that Executive is waiving and releasing any rights Executive may have under the ADEA and that the waiver and release is knowing and voluntary. Executive agrees that this waiver and release does not apply to
any rights or claims that may arise under the ADEA after the date Executive executes this Agreement. Executive acknowledges that the consideration given for this waiver and release is in addition to anything of value to which Executive was already
entitled. Executive further acknowledges that Executive has been advised by this writing that: (a)&nbsp;Executive should consult with an attorney <U>prior</U> to executing this Agreement; (b)&nbsp;nothing in this Agreement prevents or precludes
Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties or costs for doing so, unless specifically authorized by federal law;
(c)&nbsp;Executive has seven (7)&nbsp;days following the execution of this Release to revoke this Release and may do so by writing to the Company&#146;s General Counsel; (d)&nbsp;this Release shall not be effective until after the revocation period
has expired without revocation; and (e)&nbsp;nothing in this Release prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent,
penalties or costs for doing so, unless specifically authorized by federal law. In the event Executive signs this Release and returns it to the Company in less than the <FONT STYLE="white-space:nowrap">21-day</FONT> period identified above,
Executive hereby acknowledges that Executive has freely and voluntarily chosen to waive the time period allotted for considering this Release. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Unknown Claims</U>. Executive acknowledges that Executive has been advised to consult with legal counsel and that Executive is familiar
with the principle that a general release does not extend to claims that the releaser does not know or suspect to exist in Executive&#146;s favor at the time of executing the release, which, if known by Executive, must have materially affected
Executive&#146;s settlement with the Releasee. Executive, being aware of said principle, agrees to expressly waive any rights Executive may have to that effect, as well as under any other statute or common law principles of similar effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>No Pending or Future Lawsuits</U>. Executive represents that Executive has no lawsuits, claims, or actions pending (directly or
indirectly) in Executive&#146;s name, or on behalf of any other person or entity, against the Company or any of the other Releasees. Executive also represents that Executive does not intend to bring any claims (directly or indirectly) on
Executive&#146;s own behalf or on behalf of any other person or entity against the Company or any of the other Releasees. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Confidentiality</U>. Executive reaffirms and agrees to observe and abide by the
&#147;Agreement Relating to Patents, Copyrights, Inventions, Confidentiality and Proprietary Information&#148; entered into between Executive and the Company and any and all amendments and supplements thereto (the &#147;Confidentiality
Agreement&#148;). For the avoidance of doubt, Confidential Information thereunder includes, without limitation, information or materials regarding the Company&#146;s plans, strategies, governance or operations, deliberations, including any
discussions or deliberations relating thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U><FONT STYLE="white-space:nowrap">Non-Competition</FONT> and <FONT
STYLE="white-space:nowrap">Non-Solicitation</FONT></U>. Executive agrees that for a period ending one (1)&nbsp;year after the Separation Date: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. Executive shall not, directly or indirectly, whether for himself or for any other person, company, corporation or other entity be or become
associated in any way (including but not limited to the association set forth in (i)-(vii) of this subsection) with any business or organization which is directly or indirectly engaged in the research, development, manufacture, production,
marketing, promotion or sale of any product the same as or similar to those of the Company, or which competes or intends to compete in any line of business with the Company. Notwithstanding the foregoing, Executive may during the period in which
this paragraph is in effect own stock or other interests in corporations or other entities that engage in businesses the same or substantially similar to those engaged in by the Company; <U>provided</U> that Executive does not, directly or
indirectly (including without limitation as the result of ownership or control of another corporation or other entity), individually or as part of a group (as that term is defined in Section&nbsp;13(d) of the Securities Exchange Act of 1934, as
amended, and the rules and regulations promulgated thereunder)&nbsp;(i) control or have the ability to control the corporation or other entity; (ii)&nbsp;provide to the corporation or entity, whether as an executive, consultant or otherwise, advice
or consultation; (iii)&nbsp;provide to the corporation or entity any confidential or proprietary information regarding the Company or its businesses or regarding the conduct of businesses similar to those of the Company; (iv)&nbsp;hold or have the
right by contract or arrangement or understanding with other parties to hold a position on the board of directors or other governing body of the corporation or entity or have the right by contract or arrangement or understanding with other parties
to elect one or more persons to any such position; (v)&nbsp;hold a position as an officer of the corporation or entity; (vi)&nbsp;have the purpose to change or influence the control of the corporation or entity (other than solely by the voting of
his shares or ownership interest); or (vii)&nbsp;have a business or other relationship, by contract or otherwise, with the corporation or entity other than as a passive investor in it; <U>provided</U>, <U>however</U>, that Executive may vote his
shares or ownership interest in such manner as he chooses provided that such action does not otherwise violate the prohibitions set forth in this sentence. Executive shall be permitted to request a waiver of this Section&nbsp;8(a), provided that any
such waiver shall be subject to the sole discretion of the Company (not to be unreasonably withheld). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. Executive will not, either
directly or indirectly, either for himself or for any other person, partnership, firm, company, corporation or other entity, contact, solicit, divert or take away any of the customers or suppliers of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. Executive will not solicit, entice or otherwise induce any employee of the Company to
leave the employ of the Company for any reason whatsoever; nor will Executive directly or indirectly aid, assist or abet any other person or entity in soliciting or hiring any employee of the Company, nor will Executive otherwise interfere with any
contractual or other business relationships between the Company and its employees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Trade Secrets and Confidential
Information/Company Property/Inquiries</U>. Executive&#146;s signature below constitutes Executive&#146;s representation that as of the Separation Date, Executive shall (a)&nbsp;remove from any and all devices, records, files, folders, cameras,
media, internet sites, electronic or digital devices, and any and all other sources, all documents, tapes, photographs, recordings, images, reproductions, electronic files and other items provided to Executive by the Company and/or any of the
Releasees, developed or obtained by Executive in connection with Executive&#146;s employment with the Company, or otherwise belonging to the Company and/or any of the Releasees, and (b)&nbsp;return all documents, tapes, photographs, recordings,
images, reproductions, electronic files and other items provided to Executive by the Company, developed or obtained by Executive in connection with Executive&#146;s employment with the Company, or otherwise belonging to the Company, including but
not limited to any personal computer(s), BlackBerry, iPhone, iPad, tapes, photographs, recordings, images, reproductions, electronic files and other items. Executive further represents that Executive shall not misuse or disclose any of the
Company&#146;s and/or any of the Releasees&#146; confidential, proprietary or trade secret information to any third party other than good faith disclosure to a law enforcement or authorized regulatory agency of the United States Government or any
state or local government. In addition, Executive shall abide by the Company&#146;s external communication policy, such that in the event Executive receives any media, financial community or other third-party inquiries regarding the Company, except
as provided in this Section&nbsp;9 and Section&nbsp;10 of this Agreement, Executive shall not respond (nor shall Executive initiate any such contact) and shall promptly notify the Company&#146;s Global Public Affairs Department at 724.514.1968 or
<U>gpa@viatris.com</U>, or any successor department. Pursuant to the Defend Trade Secrets Act of 2016, Executive is hereby notified that an individual may not be held criminally or civilly liable under any federal or state trade secret law for the
disclosure of a trade secret that (i)&nbsp;is made in confidence to a federal, state or local government official (directly or indirectly) or to an attorney solely for the purpose of reporting or investigating a suspected violation of law or
(ii)&nbsp;is made in a complaint or other document filed in a lawsuit or other proceeding, if (and only if) such filing is made under seal. In addition, an individual who files a lawsuit for retaliation by an employer for reporting a suspected
violation of law may disclose the trade secret to the individual&#146;s attorney and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the
trade secret, except pursuant to court order. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Limits on Cooperation; Compliance</U>. Executive agrees that Executive shall not
knowingly encourage, counsel or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges or complaints by any third party, against any of the Releasees, other than good faith
assistance to a law enforcement or authorized regulatory agency of the United States Government or any state or local government. Executive may, however, respond to a lawful subpoena or other court order to do so or as related directly to the ADEA
waiver in this Agreement or as otherwise required by law. Executive agrees both to promptly notify the Company upon receipt of any such subpoena or court order, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and to furnish, within three (3)&nbsp;business days of its receipt, a copy of such subpoena or other court order. If approached by anyone, other than a law enforcement or authorized regulatory
agency of the United States Government or any state or local government, for counsel or assistance in the presentation or prosecution of any disputes, differences, grievances, claims, charges or complaints against any of the Releasees, Executive
shall state no more than that Executive cannot provide counsel or assistance. If approached for counsel or assistance as aforementioned, whether by private parties or law enforcement or regulatory agencies, Executive shall promptly notify the
Company of such an occurrence, and provide information to the Company regarding any such communication. While Executive may respond in good faith to lawful inquiries by law enforcement or regulatory agencies, Executive shall notify any such agencies
of Executive&#146;s obligations with respect to confidentiality under this Agreement, the Confidentiality Agreement, and any other applicable agreements, and Executive shall continue to honor such obligations in the course of responding to law
enforcement or regulatory agency inquiries, as lawfully permitted. Executive understands that nothing contained in this Agreement limits Executive&#146;s ability to file a charge or complaint with the Securities and Exchange Commission (the
&#147;SEC&#148;) pursuant to Section&nbsp;21F of the Securities Exchange Act of 1934, as amended, limits Executive&#146;s ability to communicate with the SEC pursuant to such provision or limits Executive&#146;s right to receive an award for
information provided to the SEC pursuant to such provision. Furthermore, Executive hereby represents that Executive is not aware of any violation of any law, Company policy or the Company&#146;s Code of Conduct in any event which could cause harm
(financial or otherwise) to the Company or any of its subsidiaries, parents or affiliates or their respective properties, shareholders, employees or prospects, other than matters which Executive has previously reported to the Office of Global
Compliance, the Viatris Legal Department or any successor department. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Executive shall use Executive&#146;s best efforts to consult with
the Company and respond to the Company&#146;s reasonable requests for information or <FONT STYLE="white-space:nowrap">follow-up</FONT> assistance pertaining to work Executive performed on behalf of the Company and/or any subsidiary or affiliate, or
other matters in which Executive was involved or of which Executive was otherwise aware, prior to the Separation Date. Executive&#146;s obligations hereunder shall include, without limitation, Executive&#146;s response to requests of legal counsel
for the Company and/or any subsidiary or affiliate regarding any legal matters or proceedings of any kind currently pending or which may arise after the Separation Date. The Company shall reimburse Executive for any expenses incurred by Executive in
connection with such requests or assistance if approved by the Company&#146;s Legal Department and supported by required documentation. No payment made to Executive hereunder is intended to be or shall be interpreted as a payment for testimony in
any legal matter. Executive understands that Executive is to provide Executive&#146;s good faith assistance, and agrees to provide truthful responses to any requests for information or testimony. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U><FONT STYLE="white-space:nowrap">Non-Disparagement</FONT></U>. Executive agrees to refrain from any disparaging statements, including
but not limited to statements that amount to libel or slander, about the Company, its direct and indirect parents, subsidiaries or affiliated companies, and/or any of its or their current or former employees, officers or directors, and/or any of the
other Releasees including, without limitation, the business, products, governance, intellectual property, financial standing, future prospects or other employment, compensation, benefit or personnel practices of the Company and/or any of the
Releasees. Executive further agrees to refrain from any disparaging statements, including but not limited to libel or slander, about any of the Releasees </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that pertain to any personal or confidential matters that may cause embarrassment to any of the Releasees or may result in any adverse effect on the professional or personal reputation of any of
the Releasees. The foregoing restrictions shall not apply to any testimony that Executive is compelled by law to give (whether written or verbal). The Company agrees to instruct its executive officers to refrain from any disparaging statements,
including but not limited to libel or slander, about Executive that pertain to any personal or confidential matters that may cause embarrassment to Executive or may result in any adverse effect on the professional or personal reputation of
Executive. The foregoing restrictions shall not apply to any testimony that any executive officer of the Company is compelled to give by law (whether written or verbal). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Breach</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a.
<U>Material Breach of Agreement</U>. In addition to the rights provided in Section&nbsp;20 below, if Executive commits a material breach of this Agreement, which shall include, without limitation, any breach of Sections 7, 8, 9, 10 and 11 of this
Agreement and any breach of the Confidentiality Agreement, the Company shall be entitled to immediately recover and/or cease providing the payments and consideration provided to Executive under this Agreement (including, for the avoidance of doubt,
canceling any equity awards Executive holds) and to obtain damages, except as provided by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. Executive also acknowledges and agrees
that Executive&#146;s compliance with Sections 7, 8, 9, 10 and 11 of this Agreement and the Confidentiality Agreement (as amended by this Agreement) is <U>of the essence</U>. The Parties agree that if the Company and/or any of the Releasees proves
that Executive breached, intends to breach or will breach any of these provisions (Sections 7, 8, 9, 10 or 11 of this Agreement or the Confidentiality Agreement), without limiting any other remedies available to the Company and/or any of the
Releasees, the Company and/or any of the Releasees shall be entitled to an injunction restraining Executive from any future or further breaches and an award of its costs spent enforcing the applicable provision(s), including all reasonable
attorneys&#146; fees associated with the enforcement action as provided in Section&nbsp;20, without regard to whether the Company and/or any of the Releasees can establish actual damages from Executive&#146;s breach. Any such individual breach or
disclosure shall not excuse Executive from Executive&#146;s obligations hereunder, nor permit Executive to make additional disclosures. Executive expressly agrees and warrants that Executive shall not, in violation of the terms of Sections 7, 8, 9,
10 or 11 of this Agreement and the Confidentiality Agreement disclose, orally or in writing, directly or indirectly, any of the Company&#146;s confidential, proprietary or trade secret information to any third party other than good faith disclosure
to a law enforcement or authorized regulatory agency of the United States Government or any state or local government. Executive warrants that Executive has not encouraged or assisted any attorneys or their clients in the presentation or prosecution
of any disputes against the Company and/or any of the Releasees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>No Admission of Liability/Compromise</U>. No action taken by the
Company and/or any of the Releasees, either previously or in connection with this Agreement, shall be deemed or construed to be (a)&nbsp;an admission of the truth or falsity of any actual or potential claims or (b)&nbsp;an acknowledgment or
admission by the Company and/or any of the Releasees of any fault or liability. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Costs</U>. The Parties shall each bear their own costs, attorneys&#146; fees and
other fees incurred in connection with the preparation of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Choice of Law and Forum</U>. This Agreement shall be
construed and enforced according to, and the rights and obligations of the parties shall be governed in all respects by, the laws of the Commonwealth of Pennsylvania without reference to the principles of conflicts of law thereof. Any controversy,
dispute or claim arising out of or relating to this Agreement, or the breach hereof, including a claim for injunctive relief, or any claim which in any way arises out of or relates to Executive&#146;s employment with the Company or separation from
said employment (whether such dispute arises under any federal, state or local statute or regulation, or at common law), including but not limited to statutory claims for discrimination, shall be resolved by arbitration in accordance with the
then-current rules of the American Arbitration Association respecting employment disputes pertaining at the time the dispute arises; <I>provided</I>,<I> however</I>,<I> </I>that either party may seek an injunction in aid of arbitration with respect
to enforcement of Sections 7, 8, 9, 10 and/or 11 of this Agreement from any court of competent jurisdiction. The Parties agree that the hearing of any such dispute shall be held in Pennsylvania. The decision of the arbitrator(s) shall be final and
binding on all parties and any award rendered shall be enforceable upon confirmation by a court of competent jurisdiction. Any arbitration proceedings, decision or award rendered hereunder, and the validity, effect and interpretation of this
arbitration provision shall be governed by the Federal Arbitration Act, 9 U.S.C. &#167; 1 <I>et seq</I>. Executive and the Company expressly consent to the jurisdiction of any such arbitrator over them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Tax Consequences</U>. The Company makes no representations or warranties with respect to the tax consequences of the payments and any
other consideration provided to Executive or made on Executive&#146;s behalf under the terms of this Agreement. Executive agrees and understands that Executive is responsible for payment, if any, of local, state and/or federal taxes on the payments
and any other consideration provided hereunder by the Company and any penalties or assessments thereon. Executive further agrees to indemnify and hold the Company harmless from any claims, demands, deficiencies, penalties, interest, assessments,
executions, judgments or recoveries by any government agency against the Company for any amounts claimed due on account of (a)&nbsp;Executive&#146;s failure to pay or delayed payment of federal or state taxes or (b)&nbsp;damages sustained by the
Company by reason of any such claims, including attorneys&#146; fees and costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The intent of the parties is that payments and benefits
under this Agreement comply with Section&nbsp;409A of the Internal Revenue Code (the &#147;Code&#148;) to the extent subject thereto, and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted and administered to be in
compliance therewith. Notwithstanding anything contained herein to the contrary, to the extent required in order to avoid accelerated taxation and/or tax penalties under Section&nbsp;409A of the Code, Executive shall not be considered to have
terminated employment with the Company for purposes of this Agreement and no payments shall be due to Executive under Section&nbsp;1 of this Agreement until Executive would be considered to have incurred a &#147;separation from service&#148; from
the Company within the meaning of Section&nbsp;409A of the Code. For purposes of this Agreement, each amount to be paid or benefit to be provided shall be construed as a separate identified payment for purposes of Section&nbsp;409A of the Code, and
any payments described in Section&nbsp;1 that are due within the &#147;short term deferral period&#148; as defined in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Section&nbsp;409A of the Code shall not be treated as deferred compensation unless applicable law requires otherwise. To the extent required in order to avoid accelerated taxation and/or tax
penalties under Section&nbsp;409A of the Code, amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to this Agreement during the <FONT STYLE="white-space:nowrap">six-month</FONT> period immediately following
Executive&#146;s termination of employment shall instead be paid in a lump sum on the first regularly scheduled Company payroll date occurring after the <FONT STYLE="white-space:nowrap">six-month</FONT> anniversary of the Separation Date (or death,
if earlier). To the extent required to avoid an accelerated or additional tax under Section&nbsp;409A of the Code, amounts reimbursable to Executive under this Agreement shall be paid to Executive on or before the last day of the year following the
year in which the expense was incurred and the amount of expenses eligible for reimbursement (and <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits provided to Executive) during any one year may not affect amounts reimbursable or provided in
any subsequent year; <I>provided</I>, <I>however</I>, that with respect to any reimbursements for any taxes which Executive would become entitled to under the terms of the Agreement, the payment of such reimbursements shall be made by the Company no
later than the end of the calendar year following the calendar year in which Executive remits the related taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>Authority</U>.
The Company represents and warrants that the undersigned has the authority to act on behalf of the Company and to bind the Company and all who may claim through it to the terms and conditions of this Agreement. Executive represents and warrants that
Executive has the capacity to act on Executive&#146;s own behalf and on behalf of all who might claim through Executive to bind them to the terms and conditions of this Agreement. Each Party warrants and represents that there are no liens or claims
of lien or assignments in law or equity or otherwise of or against any of the claims or causes of action released herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <U>No
Representations</U>. Executive represents that Executive has had an opportunity to consult with an attorney and has carefully read and understands the scope and effect of the provisions of this Agreement. Executive has not relied upon any
representations or statements made by the Company that are not specifically set forth in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <U>Severability</U>. In the
event that any provision or any portion of any provision hereof or any surviving agreement made a part hereof becomes or is declared by a court of competent jurisdiction or arbitrator to be illegal, unenforceable or void, this Agreement shall
continue in full force and effect without said provision or portion of provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <U>Attorneys&#146; Fees</U>. Except with regard to
a legal action challenging or seeking a determination in good faith of the validity of the waiver herein under the ADEA or otherwise prohibited by law, in the event that either Party brings an action to enforce or effect its rights under this
Agreement, the prevailing Party shall be entitled to recover its costs and expenses, including the costs of mediation, arbitration, litigation, court fees and reasonable attorneys&#146; fees incurred in connection with such an action. Such costs and
expenses shall be paid to the prevailing party as soon as practicable after the legal action is resolved and in no event later than March&nbsp;15 of the year following resolution of the legal action. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. <U>Entire Agreement</U>. This Agreement and the Confidentiality Agreement (as amended by
this Agreement) represent the entire agreement and understanding between the Company and Executive concerning the subject matter of this Agreement and Executive&#146;s employment with and separation from the Company and the events leading thereto
and associated therewith, and supersede and replace any and all prior negotiations, representations, agreements and understandings concerning the subject matter of such agreements, Executive&#146;s relationship with the Company and Executive&#146;s
obligations following employment with the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. <U>No Oral Modification</U>. This Agreement may only be amended in a writing
signed by Executive and the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23. <U>Governing Law</U>. The laws of the Commonwealth of Pennsylvania govern this Agreement,
without regard for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">choice-of-law</FONT></FONT> provisions. Executive consents to personal and exclusive jurisdiction and venue in the Commonwealth of Pennsylvania. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24. <U>Effective Date</U>. This Agreement shall become immediately effective upon Executive&#146;s execution and delivery of this Agreement to
the Company; <I>provided</I> that if Executive fails to comply with this Agreement (including the execution and <FONT STYLE="white-space:nowrap">non-revocation</FONT> of the Release pursuant to Sections 3 and 4), Executive shall not receive the
amounts or benefits set forth in Section&nbsp;1, and this Agreement shall never go into effect. Executive acknowledges and agrees that Executive shall execute this Agreement on, and in any event no earlier than one week prior to, the Separation
Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25. <U>Counterparts</U>. This Agreement may be executed in counterparts and by facsimile, and each counterpart and facsimile shall
have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">26. <U>Voluntary Execution of Agreement</U>. Executive understands and agrees that Executive executed this Agreement voluntarily, without any
duress or undue influence on the part or behalf of the Company and/or any of the Releasees or any third party, with the full intent of releasing all of Executive&#146;s claims against the Company and any of the other Releasees. Executive
acknowledges that: (a)&nbsp;Executive has read this Agreement; (b)&nbsp;Executive has been represented in the preparation, negotiation and execution of this Agreement by legal counsel of Executive&#146;s own choice or has elected not to retain legal
counsel; (c)&nbsp;Executive understands the terms and consequences of this Agreement and of the releases it contains; (d)&nbsp;Executive is fully aware of the legal and binding effect of this Agreement and (e)&nbsp;Executive has been given the
toll-free telephone number of the Pennsylvania Bar Association to help Executive identify a qualified lawyer <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(800-692-7375).</FONT></FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have executed this Agreement on the respective dates set
forth below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dated: February&nbsp;24, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ Michael Goettler</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Michael Goettler</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">VIATRIS INC.:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dated: February&nbsp;24, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ Andrew Enrietti</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Andrew Enrietti</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Human Resources Officer</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>d452663dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Viatris Announces Appointment of Scott A. Smith as CEO Effective April&nbsp;1, 2023 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Smith, a seasoned senior healthcare executive, will lead the company&#146;s previously announced Phase 2 strategy and execution </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Board of Directors thanks Michael Goettler, who will support </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>a smooth transition prior to his departure </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PITTSBURGH &#150; February</B><B></B><B>&nbsp;27, 2023</B> &#150; Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that as it
prepares to enter Phase 2 of its previously announced strategic plan in 2024, Scott A. Smith has been appointed by its Board of Directors to lead the execution of that plan as Viatris&#146; new Chief Executive Officer, effective April&nbsp;1, 2023.
In the interim, current CEO Michael Goettler will be working closely with Smith to support a smooth transition and will then depart as CEO and as a member of the board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Smith has been a member of the Viatris Board since December 2022 and is a deeply knowledgeable senior global biotechnology and pharmaceutical executive with
more than 35 years of experience. As a former President and Chief Operating Officer at Celgene Corporation, he rose up the ranks, including holding the roles of SVP and Global Head of Immunology, as well as President of Inflammation and Immunology.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Most recently, he served as President of BioAtla, Inc., a publicly traded global biotechnology company focused on the development of Conditionally Active
Biologics <SUP STYLE="font-size:75%; vertical-align:top">TM</SUP> (BAC) antibody therapeutics. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Viatris Board believes that Smith is a seasoned
builder who possesses vast global commercial and pharmaceutical expertise and a proven ability to build, grow and manage large complex organizations. He also has substantial experience in developing and executing regulatory, clinical, and business
development strategies. One of his many achievements during his <FONT STYLE="white-space:nowrap">10-year</FONT> career at Celgene was to build and oversee the clinical development, registration, launch and global commercial success of the
blockbuster drug Otezla<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Robert J. Coury, Executive Chairman of Viatris said, &#147;As we now
prepare to enter into Phase 2 of our evolution for 2024 and beyond, we believe Scott Smith is the absolute right leader to guide Viatris into a period of renewed growth and leadership in our sector. The Board sees his strong commercial and strategic
expertise being complemented by his experience in organically building product franchises, business development and partnering activities. I have personally been extremely impressed with his overall approach to leadership, deep industry knowledge
and forward-looking business mindset. The Board believes that the foundation is now firmly in place for Phase 2 of the company&#146;s strategic plan, including the recent divestiture of our biologics business to Biocon Biologics as well as our other
upcoming planned divestitures, and the recent establishment of the Viatris Eye Care Division. This positions Scott well to expand upon and grow Viatris&#146; success in the years ahead.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Smith said, &#147;It is an incredibly exciting time to become Viatris&#146; CEO. I watched closely in November as the company laid out the next important
steps in its well-crafted strategic plan, including its commitment to its future capital allocation priorities, which I totally support. Since then, and particularly after joining the </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
board and seeing their incredible level of engagement, I have been extremely impressed by everyone that I have met during this process and have also been inspired by all that has been
accomplished in such a short period of time. Just as importantly, I am also motivated by the Company&#146;s strong financial profile and financial flexibility, including one of the strongest balance sheets in the sector. I can see many additional
opportunities and options for Viatris to accelerate its growth in the coming years.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Smith continued, &#147;I believe that my background in
franchise building, business development and biotech, coupled with the great platform we have to work from, can accelerate Viatris&#146; momentum and help deliver on its full value and potential. I look forward to collaborating with Michael during
this transition and am very excited about the prospect of working together with the board, Rajiv Malik, Sanjeev Narula, the entire management team, and especially the company&#146;s 37,000 employees around the world on the execution ahead.&#148;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Coury added, &#147;The Board of Directors and I would like to personally thank Michael Goettler for his service and dedication during the critical time
of the creation of Viatris and the establishment and ongoing execution of our Phase 1 strategy. There is a lot that has been accomplished and we are deeply grateful for the important part he played in the Company&#146;s success to date. We wish him
nothing but the best as he moves forward.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goettler stated, &#147;It has been my sincere honor to serve as Viatris&#146; first CEO. Having had the
opportunity to help create a new kind of global healthcare company has been an experience that I will never forget and always value. I am incredibly proud of our eight consecutive quarters of successful performance and the work that we have done to
set up Viatris for long-term success. I want to thank Robert, the entire Viatris Board of Directors, the management team and especially the thousands of Viatris colleagues with whom I have had the privilege to share this journey. I am pleased to
welcome Scott into Viatris and am looking forward to supporting him during this transition, as he is well positioned to continue to build on the Company&#146;s momentum.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Coury and Smith will be joining Goettler, Malik and Narula for Viatris&#146; previously announced fourth quarter and full year 2022 financial results
conference call later this morning at 8:30 a.m. ET. Investors and the general public are invited to listen to a live webcast of the call at<U> investor.viatris.com or</U> by calling 866.342.8591 or 203.518.9713 for international callers (Conference
ID: VTRSQ422). A replay of the webcast also will be available on the website. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About&nbsp;Viatris</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Viatris Inc.&nbsp;(NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to
medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">one-of-a-kind</FONT></FONT></FONT> Global Healthcare Gateway<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>. Formed in&nbsp;November 2020, Viatris brings together scientific, manufacturing and distribution
expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris&#146; portfolio comprises more than 1,400 approved molecules across a wide range
of therapeutic areas, spanning both <FONT STYLE="white-space:nowrap">non-communicable</FONT> and infectious diseases, including globally recognized brands, complex generic and branded medicines and a variety of <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> consumer products. With approximately 37,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in&nbsp;Pittsburgh,&nbsp;Shanghai&nbsp;and&nbsp;Hyderabad, India.
Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube.</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-looking Statements</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release includes statements that constitute &#147;forward-looking statements.&#148; These statements are made pursuant to the safe harbor provisions
of the Private Securities Litigation Reform Act of 1995. Such forward looking statements may include statements about Viatris&#146; Phase 2 strategy, Viatris entering into a period of renewed growth and leadership in its sector; that the foundation
is now firmly in place for Phase 2 of Viatris&#146; strategic plan, including the recent divestiture of its biologics business to Biocon Biologics as well as its other upcoming planned divestitures, and the recent establishment of the Viatris Eye
Care Division; future capital allocation priorities; additional opportunities and options for Viatris to accelerate its growth in the coming years; and acceleration of Viatris&#146; momentum and delivering on its full value and potential; that this
positions Scott well to expand upon and grow Viatris&#146; success in the years ahead. Factors that could cause or contribute to such differences include, but are not limited to: the possibility that the Company may be unable to realize the intended
benefits of, or achieve the intended goals or outlooks with respect to, its strategic initiatives; the possibility that the Company may be unable to achieve expected benefits, synergies and operating efficiencies in connection with acquisitions,
divestitures, or its global restructuring program, within the expected timeframe or at all; impairment charges or other losses related to the divestiture or sale of businesses or assets; the Company&#146;s failure to achieve expected or targeted
future financial and operating performance and results; the potential impact of public health outbreaks, epidemics and pandemics, including the ongoing challenges and uncertainties posed by <FONT STYLE="white-space:nowrap">COVID-19;</FONT> actions
and decisions of healthcare and pharmaceutical regulators; changes in healthcare and pharmaceutical laws and regulations in the U.S. and abroad; any regulatory, legal or other impediments to Viatris&#146; ability to bring new products to market,
including but not limited to <FONT STYLE="white-space:nowrap">&#147;at-risk&#148;</FONT> launches; Viatris&#146; or its partners&#146; ability to develop, manufacture, and commercialize products; the scope, timing and outcome of any ongoing legal
proceedings, and the impact of any such proceedings; any significant breach of data security or data privacy or disruptions to our information technology systems; risks associated with international operations; the ability to protect intellectual
property and preserve intellectual property rights; changes in third-party relationships; the effect of any changes in Viatris&#146; or its partners&#146; customer and supplier relationships and customer purchasing patterns; the impacts of
competition; changes in the economic and financial conditions of Viatris or its partners; uncertainties and matters beyond the control of management, including general economic conditions, inflation and exchange rates; failure to execute stock
repurchases consistent with current expectations; stock price volatility; and the other risks described in Viatris&#146; filings with the Securities and Exchange Commission (SEC). Viatris routinely uses its website as a means of disclosing material
information to the public in a broad, <FONT STYLE="white-space:nowrap">non-exclusionary</FONT> manner for purposes of the SEC&#146;s Regulation Fair Disclosure (Reg FD). Viatris undertakes no obligation to update these statements for revisions or
changes after the date of this release other than as required by law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For further information: MEDIA, +1.724.514.1968, Communications@viatris.com,
Jennifer Mauer, Jennifer.Mauer@viatris.com, Matt Klein, Matthew.Klein@viatris.com; INVESTORS: Bill Szablewski, +1.412.707.2866, InvestorRelations@viatris.com; William.Szablewski@viatris.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>vtrs-20230224.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 2/28/2023 12:02:57 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:vtrs="http://www.viatris.com/20230224"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.viatris.com/20230224"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtrs-20230224_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtrs-20230224_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>vtrs-20230224_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 2/28/2023 12:02:57 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>vtrs-20230224_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 2/28/2023 12:02:57 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="vtrs-20230224.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g452663g0227185324928.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g452663g0227185324928.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  _ -4# 2(  A$! Q$!_\0
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M523^9VC\Z\3^-\CMXX@1B=JV2;1_P)ZZKXC:M)IWC[2KA<D6D4<H7U^=B?S
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M -U$?-@]V';\1D?7%?/I$EO,0=T<D;?0J17HT5&M1Y'NCI@E.'*SW+4+C4=
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@0 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140077233884640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 24, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Viatris Inc<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001792044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 24,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-4364296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1000 Mylan Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Canonsburg<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">15317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(724)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">514-1800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VTRS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>d452663d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vtrs-20230224.xsd" xlink:type="simple"/>
    <context id="duration_2023-02-24_to_2023-02-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <startDate>2023-02-24</startDate>
            <endDate>2023-02-24</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2023-02-24_to_2023-02-24"
      id="Hidden_dei_EntityRegistrantName">Viatris Inc</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2023-02-24_to_2023-02-24">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-02-24_to_2023-02-24"
      id="Hidden_dei_EntityCentralIndexKey">0001792044</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-02-24_to_2023-02-24">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-02-24_to_2023-02-24">2023-02-24</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-02-24_to_2023-02-24">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-02-24_to_2023-02-24">001-39695</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-02-24_to_2023-02-24">83-4364296</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-02-24_to_2023-02-24">1000 Mylan Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-02-24_to_2023-02-24">Canonsburg</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-02-24_to_2023-02-24">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-02-24_to_2023-02-24">15317</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-02-24_to_2023-02-24">(724)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-02-24_to_2023-02-24">514-1800</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-02-24_to_2023-02-24">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-02-24_to_2023-02-24">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-02-24_to_2023-02-24">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-02-24_to_2023-02-24">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-02-24_to_2023-02-24">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-02-24_to_2023-02-24">VTRS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-02-24_to_2023-02-24">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-02-24_to_2023-02-24">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%
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M?^:+X3]>?P%02P$"% ,4    " #$@EM6!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( ,2"6U86"*'_
M[0   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( ,2"6U:97)PC$ 8  )PG   3              "  <L!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ Q();5C_/=BQ#!   B!
M !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( ,2"6U:?H!OPL0(  .(,   -              "  84,  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ Q();5I>*NQS     $P(   L
M         ( !80\  %]R96QS+RYR96QS4$L! A0#%     @ Q();5APX9>H_
M 0  / (   \              ( !2A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( ,2"6U8D'INBK0   /@!   :              "  ;81  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( ,2"6U9ED'F2&0$
M ,\#   3              "  9L2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     )  D /@(  .43      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d452663d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  d452663d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="d452663d8k.htm">d452663d8k.htm</File>
    <File>d452663dex101.htm</File>
    <File>d452663dex102.htm</File>
    <File>d452663dex991.htm</File>
    <File>vtrs-20230224.xsd</File>
    <File>vtrs-20230224_lab.xml</File>
    <File>vtrs-20230224_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d452663d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d452663d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "vtrs-20230224_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vtrs-20230224_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "vtrs-20230224.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "vtrs",
   "nsuri": "http://www.viatris.com/20230224",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d452663d8k.htm",
      "contextRef": "duration_2023-02-24_to_2023-02-24",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d452663d8k.htm",
      "contextRef": "duration_2023-02-24_to_2023-02-24",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230224/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001193125-23-050797-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-050797-xbrl.zip
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M\)L6-F<R_LP]CP7V,S0YM]I/N/>A]).Y]3L8WN_= (B<7[$15\A>?4XG0%
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M8<$1:%NW7L\DIEIN.X??&14;\K*\:H4\%A*5Q&_ \L\L%N[^O:;M,/;=H19
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ML01\O9:QZ: X\KT!),1DK2H1E9<)64UEY24IR>PNGOS>+31.69_X#=.]?1O
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M%1)L!G)"@OY6FV 28(KUV210:1T8]8(H7ODT4 HTM2&XEY/:3D()%6[!<GY
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M"*4G^XF'3\'AAGU9MF%J]D[HLJ5T#A2@0G%+BWX?^&NWHZ8H1B\,GPD],2U
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MB1H?K;:R,JYH4S!-W&U"I@1T#,BH)LO\5H8'"0Q.!%]B^<I-2%KLT];@G<G
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M[KXA5>K>LPN?")N8OS(SS(.'YH$KZ=U_J(F2U19/1#/)O">I8I/D6PM"C4Z
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MV.EL/24UF?B[C:D]^A%3^],%EPGS.W@D15;/8]]-%T_7VKHG6MB%@*A60(X
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M6JM*B=EUVJ]<><.4L(D[Y6PGQ\%*.P,)DCIG9#?<_N(PE;XVDVT*L"3HL*#
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MR ':<DI&QT3&0 VY[=]GP.G>YH#3L[LOWKWZ-US\Y>S7-\__'U!+ P04
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MO=C:V=[^6U.A'Y^^NSJ]^#_7-\/+N=(2RC8F^-*6+0JAD8A;N?#(Y_",:(#
MI'](G^!U/%8B<1GAL_! 9JJH7RH.X])Q+)(!/( 5%[_6YKY B<SOTEP]XC6Q
M5 .])IQ(0!L8 K@BJA<D*A=4AK;IC4)GI'X".W/='W%.JG^L=";S90XY0H=\
M1& ZOD6BE.-F-D?NH10'LV<V%;G9?CN#B+2B.;O1X43,T7OE12 \!:&D"=\P
MWU0-%\4\.T;4Y+0C0?Y-8Z'0[SD.CSKG\!'%5@@14C*(M$E)'BR74OEG.!I#
M?@\3!7YF[NNRWK=44D)ZR!_@M-JTS->H&M[A#$E9)]<PMZ;:&CO=9/Q&#'PB
M\X="#)+;U9 9(9'3DN>(:.ZF5%0PDYIBP,%3U-J KG#4"J%>2^NX=:;-'$U3
M9X)6DQ:8/45F*ZG $\8#3I<ZK049!4SADH$VE"1 U ,T:>+25$]<*,_9RMA[
MD0#I]SA"-AHI@"S%E>0&*E@GD<B!25\ /X2UV*RIW-Q02FZ]P/$^4!?Z-[M4
M;\$TUP-UJ?/?C%FJ=[JLJ=;E/A0,+TVHDX35C<Z$B0W-8YFM[U <#Y\.MK>W
ME4%PNA6I1"U;24-A5]J4PVVKJYM\OWWQSSJ>8JK%8*O"UAISW)> T36,AJ<8
M+!WQR,W@VQTSBD-6QJ9<VD2@@+EL2'X-_<%SE 2IOB*60F@'!4= #1W &,]1
M,JUK)8[^?.[H?6N-0])BH@MWFIXZ:TUL*=?>J:O6"56M\2FW[&!Y:6)C:TXO
M ;YY==P]C%3*B9E:* BME7#Q710:1!<\"$D+2OZ%NER>-';6[^40CJ*/!<L3
M(WR-'S-'FC@$SO>BJF8OX>[*=$5:XR_P%#<$X:*%RZ7!SDVDV[U:J'9?B4X[
MTTNNW:7;VV5S;E,PJ?#^XS7<XT48,RC_L,G=V<&\6T>%K,N-UYQR,?D0;" L
MPH)&J&HDB;"C.\$D];0I2KF<!&O[6/;^I\:&&VE&AFTE8&!F(E;.:KJ-]VNQ
M)-+ME!6!@\Z$*771 )Q@E0++0[PYBZ\572N*4H)-JO$UBEKO-G7C5X9M4-A=
M#%8M7.WQO>^&'!&TT?,:R&#VO%FX+,J8L'\D9)?0 7-F!K_@"I]"_S=X+C>K
MX%KD(4VBB)8-1<T:7JH6KL:[,8[1L5;LY(J@B:7KDZT)J#8]#$+ V%"2Q0K)
MA'0C:;=M]K@[XS3FN.]6"@4VQMI%'\3SAJCMVR,VSE8\4A)55_"$2+OSR 9E
M=(D7!]B*9J-$3>)'NOBMA(-\K=/*]WOPUPRQ36"F1@1J)GJ679ZYDBT#JI_M
M/=Q6>I2-U.D5-CNG*C<F#M8<)J?N0>@:,Y_:?,F)F]H(%L56SEI-I=SV-Y.$
MFIXQ$7#?H3KX^9">XE>/EK+>$4"D7'GP +^#9J619-*S)T]&#Q_MCIX]?KZC
MN(?T</1XY]GH^=.=A^PN/O/)M8A)?HP"^?YQL]I^;WPB9VO_?+2[^^-('<$G
MQ.S1J&@C"^>X67JI;<I''@%5& 7TF4^VYYY]I0/&(Y) <L85T/ =3LD/NX>2
M,OGZR:3DV3^F;>@C=R,MJL(X4(2(HQMJUC$VB&;X,2L=6ZZG*"'-N9Q([4RR
M*#6[Z2$=$VR_EY':('T,3I@NI<Y !:0!<]XC.14"I0^B?@8P<H<2B&;UH0OI
M0S.0&F T)Y(!<Z*<++9M/6&7G*0GGUB%Y50N?)3&G0]%)FLBZD<@R<P7_-;/
M=K&_<$"_]XDA(,*AFPWUD#)JZ(>O_],YQHJ;]1I1CTSYW_2G7]'I'*DB 4G3
MDP'Q; \:[I\0$'RKUWUB*;W-;#*@!%;/=%()Z[.:I/Z[G? N=1NLG*?"X4?W
M^('Q$$\?.IW:1!=R1F+E&#R6,POD_"'XDD]/&C"Q^@5$^! "*J\]GMQY\ICJ
MK1Q&A9H4+ -MZTINNVYP-#+9S*76<2B4U,GMOFKP",4#-UOI/"YSP%M-QXTZ
M07U#(<41@JPW;Q1S/-XB?M7 -#8^9X:>T$GT9\&3NWQ(3JFIYXSXB'#@L]V<
M3]*14LCIE,;73D4EO)%MH#C</ <J4(&6I"0&S:D2YP R+@^_HV4U/I4#JZ6&
MIRKFV*^"=6SB$(X9\J:8<@/G).9J.C*.H0D>X0M(Y/6/-@/HL:10QW5D4%QM
M"UM+BD-/0VIMQ?_/H\O10. 8#X6XY^6;.'AOJ\I/ZG*^&,@7E]C]^4);^02W
MR ]GJRGV=Z*G= 0[M7K4[[U!W@[H RUV$Z+LV.U,&8$O),5F84.1JJ[P<R7T
M^H^P)O#Y0+VQ^;69CJ7D_M755_7$C/Z_P_C7\O.KC4.02ZJI^"CS>^1I.2V@
MMB2"E(5XB%_CI;J30U4N4B@PZ)0"U9<4?)OG-^T#41^CIO:F^R+-71-05%&7
MOFZ*%XS1,RH<RHDK)6?3:89OJO[W);<@U27X3GKC0&%EY](*N##<M#J2]L[.
M\^>/1^J2.IZQ2KAM(:Q8Q:6N&<@=HW5.WKQ_UT8X XE[_'_ZX) Z8M+0W+_K
M3*O?^[)#K8W#F[]PGD6&_/GS+'J*S[/4USW.ZO?6SK/VO^B<9+_3 U9?OP6\
M+WDH#E]O/MW5_0Q*0=K;G^Q]-GMO@?5O<VJG7NGF=B8%,;7K$ET#0*[DPI>U
MDM3H%#-3.PO5CH\!,N#6$^U+[BIHZRS4:'M2YD-YV'B9)"(Y%,X<9BB!:M'6
MF .\GH*<FCMVE/'[O0G"9<:8F@W(KG"E8VV4FCN45?1;A"A%=&@]E$8ZNY4;
M2%0U06 )!"S;_?Y?,#4:01(RX?./8"5$U JR9=X"+%XD,W21C%I,EKT7LRI!
MAFW5R7]J&W9YT.^MAPI5H%44$K2LJJRCL 4GSDMJ,=-K;&P1![NH03K#;WE+
MZ0YG"F!9K K<06&6+.@FC[B.8S;E:T1$^3I4VWP#JTL,4-DZ98*(E" OT/BA
M"N[<Z([,4.;6Y=VNHQ8@&5'1;H>8;AL+ZT[<[)6%MD/<PA ZO$!A_-! D(*0
MT,'J 1XU!>1PQM3%9Z2Y?-HDQM@EAI\@Y^@(BL=3@Z2DNI"9!-B1([#/:M#C
M\P_CD^'.\_U&*S,"O-QZF)I$DAO?86JKJ3MN;C55"M:>D (44'WZH53?^. V
M?IJGZBA/(;-)Z?24B&VU5@NE9DX4&G$"%T.+!PW@-CBG>X&,,4H=V::>I0)7
ME]>F LQ;;Q./K'/(Y]TI8D-70TQ]+<(B.E:N5U%TKYL6(BE<=+G#X%#8=\M'
MLUD $DO%Y0CV? *0#BC<8JT)K''#$EM)KHQ 8C?2O2:7&$,+[R3"%K;T!%-N
M9YQLB8< I?*6!!)A&6,P'LJ [@6R EK1&OD+ZK+J1#Y;7]8AV6&1U#U B4:A
MQ S4N8/I5QZ*![.13RFQ>X<E5_%$<+T1UG9$]L-EJL:/L+PB[J4'N/E1AW53
MT1VN\2)\N?/?':.:(7PA:QW?(#BH2MJ\E5 430W9%*:7^]O1@9WGO@0#28WR
M)PN-3NH<I]1 6IM%8!#'0:AB"L^\I*D<BEZ0?:0HIGXH J5B6M]8"<Q%#H"8
M2#:.PY-XOW6MK;YA]/X&!\GES(IK1;GX%L0*LKCC:PAM/W^M$@^=UL:6=G8:
M-DO;F\;FH]BO*(G"@ ZIRR$:R6677/=[I0F^,9YK ^[7A@(R7IH7_H_@X0<)
ML"#VI:-)"4?[36@(Z0@D48$D4"92-6^>&*7<#VJ.;3M5 ;WJ-"[AF&[=>");
M=?_R]/C'IMFB2D?74*F0K\E\N<W#3=EXX5[+QB"DZ,X0.9$J_](2OM>"2G)G
M2$&6KLDSMPZ^K+4"=Z<U6<A_\2&LEI&.EI-2>)CR3KPCJK"*F&TO&GJ'PK,E
M)#-;2GMU'[]3KTXZZT5903"Z-E14* =;YXWY=4%GCO3Z]5J-YJ<3@Y"L2L \
M(%ON%[%DH"?9-MM6D+*-W+#2]"TD3[BI@MST[9O>J*BAMTM)8.U.[:FWIR?C
MHX'Z^\[HZ>ZCT>.=1Z.=YT^>#1@FW-YBF/ZCVQKI]WXR.:@8KWJK:SIGB9]'
M_'EM,(9 M?]/:FPN/R_,S8@_=H?MJ_&[#Z>75^<7EWNHK2#Q+W\GQ7GCKRT;
M]VAG=_1T^^EH]]F3)X/FV.0B4M3ZNW[!"ZS.1NT[NK__Y@=4FW]D=>_>O4_<
M-3MX0'\OB2_YSRS_%U!+ P04    " #$@EM6+>F6E3X#  !*"P  $0   '9T
M<G,M,C R,S R,C0N>'-DO5;?;]LV$'XOT/_AIJ<-J$1+6=I&B%-D2P,$2-/"
M38>]%;1T=HA1I$923OS?[TA)CNS$GI,4]8MIWGUWW_VDCS_<51(6:*S0:ARE
MR2@"5(4NA9J/H\;&W!9"1!].7K\Z_B6.X>S\X@IBN'&NMCECM[>W23D3RFK9
M.+)@DT)7#.*XU__S^AO\U5K/88(2N46HN'5HX(]&R#+/1EF6IJ/WR=LAS"#W
M]J#D#G/(6/:>D>(!I%D^RO+#=W#Z"3X&,PJN185#K*Z71LQO'/Q:_ 8!=::5
M0BEQ">="<54(+N%K3_D-7*@B@5,I8>)AEGA:- LLD\[JG2US6]Q@Q5^_ J"$
M*9LK,ME4X\AGHDO$W=3(1)LY*YUA;EDC(Z68M-"((AI _Q_W $.5\!*[ LZX
MG090+_'YR0:(A3-VS<U"<&=$6R&?%5+_?:!?HEBI!T86BV2N%XP$F[:]7#P>
M0S8:'3!J"$=IQ@%$"O7/#H073ZDWADX>0&X/ B ].CIB0;I!J73K$736#UDK
M#-K<41*FC<-S;:HSG/%&$JI1_S9<BIG ,FA1HU:HW)K.NH;C9H[NBE=H:U[@
M4S)-[?186,0T97]_NOP:.BTZ\0" T'RBJK5QT/;@I2[";.S(IO\5]T6(_56<
M9O%!FI"Q"-2CI+=4$-B+B?2U?1:156/L3<1N:V!_B/UAF_?'V_[9&=@<9Q__
MD8\_?;M7_ _6P0]@HM752\D,=MKS:Z*X*-J5U1[WK\L]\D6]V2\%GX?#G8XW
MMTCG-?CD2FD7' V9\+H6:J:[*[KT39SWG3S!&83ME7-3&"UQ]XYCM=$U&B=H
MQ=\/0VO@QN!L'/E-'_=[YKODTX3V3*_RP,'Z>'DQ(PC*RWMZ/=8)Y\&77@Q>
M3F\EERO3OAW&D:6\R\%X_N1P:X-/#9<@EI9[*-OVJ+\,M)X<O/=S31K@#]\F
M%UN?A]7[P!R_TTI7RY;CF2X:_P+UWZ>J_*B(V?*"&LM4@54$@AZ2":E_WTM]
MQ;%G62+]=1.A>].1_] _N]["\,A5":TY&-@[9IM&-NTW%LO/ZB2<"RZ+1JYR
MWH$[C5W S6KMC[QGMAW7W?;UZJ>8;8YQ=S,<]_:J73?T\S]02P,$%     @
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MS9-V^BU"VJ1I-U#_D#2."9^(*%KQ[*:,JDMK27)'R%9;$15!+O!6""(1G%6
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M]@E +/D+4$L! A0#%     @ Q();5LTD+I9#%0  [7T   X
M ( !     &0T-3(V-C-D.&LN:'1M4$L! A0#%     @ Q();5OG\_\.["P
M#2D  !$              ( !;Q4  &0T-3(V-C-D97@Q,#$N:'1M4$L! A0#
M%     @ Q();5MR"\#QP.   N.\  !$              ( !62$  &0T-3(V
M-C-D97@Q,#(N:'1M4$L! A0#%     @ Q();5D98M"P=%   ;3D  !$
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8;6Q02P4&      < !P"^ 0  +GT

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
